Ignite Creation Date:
2024-05-06 @ 3:47 PM
Last Modification Date:
2024-10-26 @ 1:56 PM
Study NCT ID:
NCT04750863
Status:
COMPLETED
Last Update Posted:
2021-02-11
First Post:
2021-02-08
Brief Title:
Evaluation of Adult Onset Still Disease Classification Criteria and Differential Diagnosis at Eighteen Months of Follow-up
Sponsor:
Central Hospital Nancy France
Organization:
Central Hospital Nancy France
Study Overview
Official Title:
Evaluation of Adult Onset Still Disease Classification Criteria and Differential Diagnosis at Eighteen Months of Follow-up
Status:
COMPLETED
Status Verified Date:
2021-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
AOSD-DIF
Brief Summary:
Adult Onset Still Disease AOSD is an acquired inflammatory disease of unknown etiology presenting with non specific symptoms Its diagnosis rely on sets of criteria ie Fautrel Criteria and Yamaguchi Criteria However differential diagnosis might appear during follow-up of patients The aim of this study is to assess diagnostic performance of Fautral and Yamaguchi Criteria after 18 months of follow-up and to describe differential diagnosis appearing during follow-up
Detailed Description:
Adult Onset Still Disease AOSD is an acquired inflammatory disease of unknown etiology presenting with non specific symptoms Other conditions such as cancer infection or other inflammatory disease might mimick its symptoms Its diagnosis rely on sets of criteria ie Fautrel Criteria and Yamaguchi Criteria However differential diagnosis might appear during follow-up after an initial diagnosis of AOSD The aim of this study is to assess diagnostic performance of Fautral and Yamaguchi Criteria after 18 months of follow-up and to describe differential diagnosis appearing during follow-up
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None